News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,724 Results
Type
Article (40045)
Company Profile (254)
Press Release (658425)
Multimedia
Podcasts (47)
Webinars (12)
Section
Business (204426)
Career Advice (2011)
Deals (35445)
Drug Delivery (95)
Drug Development (81158)
Employer Resources (172)
FDA (16180)
Job Trends (14877)
News (345587)
Policy (32568)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2559)
Accelerated approval (5)
Adcomms (21)
Allergies (83)
Alliances (49499)
ALS (87)
Alzheimer's disease (1371)
Antibody-drug conjugate (ADC) (116)
Approvals (16181)
Artificial intelligence (242)
Autoimmune disease (20)
Automation (15)
Bankruptcy (360)
Best Places to Work (11649)
BIOSECURE Act (18)
Biosimilars (104)
Biotechnology (182)
Bladder cancer (62)
Brain cancer (26)
Breast cancer (265)
Cancer (2100)
Cardiovascular disease (167)
Career advice (1676)
Career pathing (29)
CAR-T (144)
Cell therapy (405)
Cervical cancer (19)
Clinical research (65926)
Collaboration (800)
Compensation (514)
Complete response letters (19)
COVID-19 (2592)
CRISPR (37)
C-suite (224)
Cystic fibrosis (100)
Data (2056)
Decentralized trials (2)
Denatured (17)
Depression (39)
Diabetes (258)
Diagnostics (6354)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (118)
Drug pricing (96)
Drug shortages (25)
Duchenne muscular dystrophy (91)
Earnings (86364)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (112130)
Executive appointments (695)
FDA (17373)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (723)
Gene editing (100)
Generative AI (19)
Gene therapy (288)
GLP-1 (699)
Government (4414)
Grass and pollen (4)
Guidances (51)
Healthcare (18858)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (112)
Indications (27)
Infectious disease (2732)
Inflammatory bowel disease (134)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (91)
Interviews (312)
IPO (16505)
IRA (40)
Job creations (3643)
Job search strategy (1424)
Kidney cancer (9)
Labor market (36)
Layoffs (461)
Leadership (16)
Legal (7912)
Liver cancer (72)
Lung cancer (302)
Lymphoma (140)
Machine learning (5)
Management (58)
Manufacturing (283)
MASH (62)
Medical device (13351)
Medtech (13356)
Mergers & acquisitions (19457)
Metabolic disorders (658)
Multiple sclerosis (75)
NASH (16)
Neurodegenerative disease (84)
Neuropsychiatric disorders (24)
Neuroscience (1877)
NextGen: Class of 2025 (6529)
Non-profit (4489)
Northern California (2543)
Now hiring (38)
Obesity (354)
Opinion (204)
Ovarian cancer (74)
Pain (81)
Pancreatic cancer (80)
Parkinson's disease (146)
Partnered (21)
Patents (222)
Patient recruitment (99)
Peanut (47)
People (57341)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20544)
Phase II (29029)
Phase III (21630)
Pipeline (1115)
Policy (130)
Postmarket research (2566)
Preclinical (8702)
Press Release (64)
Prostate cancer (99)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (374)
Real estate (5925)
Recruiting (65)
Regulatory (22242)
Reports (46)
Research institute (2321)
Resumes & cover letters (350)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (65)
Series A (126)
Series B (82)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2184)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3586)
State (2)
Stomach cancer (13)
Supply chain (65)
Tariffs (26)
The Weekly (28)
United States (22091)
Vaccines (670)
Venture capitalists (38)
Weight loss (229)
Women's health (34)
Worklife (15)
Date
Today (79)
Last 7 days (433)
Last 30 days (2229)
Last 365 days (32926)
2025 (9307)
2024 (35255)
2023 (40109)
2022 (51243)
2021 (55777)
2020 (54144)
2019 (46602)
2018 (35083)
2017 (32159)
2016 (31542)
2015 (37611)
2014 (31392)
2013 (26425)
2012 (28654)
2011 (29338)
2010 (27406)
Location
Africa (722)
Alabama (52)
Alaska (7)
Arizona (229)
Arkansas (13)
Asia (37858)
Australia (6203)
California (5802)
Canada (1945)
China (494)
Colorado (255)
Connecticut (262)
Delaware (137)
Europe (81195)
Florida (862)
Georgia (202)
Idaho (57)
Illinois (516)
India (25)
Indiana (301)
Iowa (10)
Japan (150)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (863)
Massachusetts (4338)
Michigan (215)
Minnesota (381)
Mississippi (2)
Missouri (79)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1665)
New Mexico (28)
New York (1659)
North Carolina (940)
North Dakota (7)
Northern California (2543)
Ohio (194)
Oklahoma (14)
Oregon (33)
Pennsylvania (1317)
Puerto Rico (11)
Rhode Island (31)
South America (1098)
South Carolina (20)
South Dakota (1)
Southern California (2184)
Tennessee (99)
Texas (864)
Utah (172)
Virginia (136)
Washington D.C. (59)
Washington State (531)
West Virginia (3)
Wisconsin (51)
698,724 Results for "northwest biotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property
Northwest Biotherapeutics announced today that on June 12, 2024 it entered into an exclusive license from Roswell Park Comprehensive Cancer Center for a portfolio of dendritic cell technologies and intellectual property (IP).
June 17, 2024
·
6 min read
Press Releases
Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference
April 16, 2025
·
1 min read
Business
Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors
Northwest Biotherapeutics announced today that it has appointed Mr. Pat Sarma to its Board of Directors effective March 18, 2024.
March 21, 2024
·
5 min read
Press Releases
Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing
December 27, 2024
·
4 min read
Business
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification
Northwest Biotherapeutics announced today that the key development work for the Flaskworks manufacturing system has been completed and an external vendor has been engaged to produce GMP-grade units of the system.
February 6, 2024
·
9 min read
BioCapital
Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Northwest Biotherapeutics provided an update today about the final preparations for the Marketing Authorization Application (MAA) that will be submitted to the Medicines and Healthcare Products Regulatory Agency (MHRA)(the equivalent of the U.S. FDA) in the U.K. for commercial approval of the Company’s DCVax®-L treatment for glioblastoma.
November 22, 2023
·
3 min read
BioCapital
Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma
Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”) announced today that a Marketing Authorization Application (MAA) was submitted yesterday to the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK for DCVax®-L for glioblastoma brain cancer.
December 21, 2023
·
7 min read
BioCapital
Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company’s Scientific Advisory Board
Northwest Biotherapeutics announces that Dr. Linda Liau, MD, PhD, MBA has joined the Company’s Scientific Advisory Board.
September 12, 2023
·
3 min read
BioCapital
Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application
Northwest Biotherapeutics provided an update about its progress toward submission of a Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency in the U.K. for commercial approval of the Company’s DCVax®-L treatment for glioblastoma.
October 13, 2023
·
4 min read
BioCapital
Northwest Biotherapeutics Announces Completion of Prerequisites, and Plans for Submission of Marketing Authorization Application
Northwest Biotherapeutics announces that it plans to submit a Marketing Authorization Application in the U.K., to the Medicines and Healthcare Products Regulatory Agency, for commercial approval of the Company’s DCVax®-L treatment for glioblastoma.
August 29, 2023
·
3 min read
1 of 69,873
Next
